Finance

Lists
MPARK:IST
MLP Saglik Hizmetleri AS
TRY 445.00
+0.23%
(+1.00) 1D
Aug 21, 6:10:00 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for MPARK...
Open
TRY 445.00
High
TRY 448.75
Low
TRY 440.75
Mkt. cap
85.00B
Avg. vol.
811.87K
Volume
475.12K
P/E ratio
13.90
52-wk high
TRY 514.00
52-wk low
TRY 304.00
EPS
TRY 32.02
Shares outstanding
191.01M
No. of employees
15K
Open
TRY 445.00
High
TRY 448.75
Low
TRY 440.75
Mkt. cap
85.00B
Avg. vol.
811.87K
Volume
475.12K
P/E ratio
13.90
52-wk high
TRY 514.00
52-wk low
TRY 304.00
EPS
TRY 32.02
Shares outstanding
191.01M
No. of employees
15K
Profile
Medical Park Hospitals Group, which has been active in the health care sector since 1995, offers service in various provinces of Turkey with more than 6,000 doctors and employees, 17 hospitals in total. Medical Park is the biggest hospital group in Turkey. The hospital chain was founded by Muharrem Usta, who currently chairs the company. The company owned two hospitals in Istanbul in 2005. In 2006, he initially sold 30% of the company shares to Sancak family. This partnership enabled a rapid growth of the company that led to the establishment of 13 hospitals with 2,000 beds within three years. By the end of 2009, 40% of the company shares were sold to the third biggest US-American global asset management firm The Carlyle Group. With this new partnership, the number of hospitals reached 17 with 2,771 beds in total that placed the company on first rank of its kind in Turkey. In March 2013, it was reported that the Carlyle Group sold its shares at Medical Park to the largest US-American private equity investment firm Texas Pacific Group. Wikipedia
About MLP Saglik Hizmetleri AS
CEOMuharrem Usta
Employees14.6K
Founded1993
Headquarters-
SectorHealth care provider
Website-
Previous reportsAll values in TRY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TRY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.06B
15.87B
17.39B
16.74B
Cost of goods sold
9.09B
11.33B
12.60B
12.60B
Cost of revenue
9.09B
11.33B
12.60B
12.60B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.06B
1.32B
1.60B
1.38B
Operating expense
1.39B
1.54B
2.13B
1.75B
Total operating expenses
10.48B
12.87B
14.73B
14.34B
Operating income
2.59B
3.00B
2.66B
2.39B
Other non operating income
235.22M
333.68M
816.86M
844.49M
EBT including unusual items
2.51B
3.24B
2.31B
1.96B
EBT excluding unusual items
2.52B
3.26B
2.31B
2.13B
Income tax expense
680.56M
1.56B
317.86M
408.37M
Effective tax rate
27.09%
48.19%
13.76%
20.85%
Other operating expenses
331.93M
213.73M
538.80M
362.22M
Net income
1.62B
1.46B
1.78B
1.37B
Net profit margin
12.39%
9.21%
10.26%
8.18%
Earnings per share
-
-
-
-
Interest and investment income
1.51B
1.68B
665.18M
671.06M
Interest expense
-1.69B
-1.75B
-1.81B
-1.73B
Net interest expenses
-177.17M
-67.71M
-1.15B
-1.06B
Depreciation and amortization charges
-
-
-
-
EBITDA
3.38B
3.94B
3.65B
3.38B
Gain or loss from assets sale
583.00K
-1.33B
-6.29M
155.54M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps